Analyst firms · Oppenheimer · AXP
Oppenheimer AXP price target and rating history
American Express Company (AXP) · Finance
Oppenheimer rates American Express Company (AXP) Outperform with a $180 price target, as of its latest action on Apr 4, 2023. It has published 3 rating actions on AXP since October 2021, including 0 upgrades and 0 downgrades. Across 4 firms with a AXP price target in the last 12 months, the median target is $384.50.
- Current rating
- Outperform
- Price target
- $180
- Median target, all firms
- $384.50
- Actions on AXP
- 3
Oppenheimer price target on AXP
Every Oppenheimer rating on AXP
- Apr 4, 2023
- Jan 26, 2022
- Oct 13, 2021
How other firms rate AXP
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BMO Capital Markets | Outperform | $380 | Oct 9, 2026 |
| Piper Sandler | Overweight | $396 | Jun 30, 2026 |
| DZ Bank | Buy | $375 | Jun 18, 2026 |
| Loop Capital | Buy | $389 | May 22, 2026 |
| Wolfe Research | Peer Perform | Dec 8, 2025 |
Questions about Oppenheimer and AXP
- What is Oppenheimer's price target for AXP?
- Oppenheimer's latest stated price target for American Express Company (AXP) is $180, from its action on Apr 4, 2023.
- What is Oppenheimer's rating on AXP?
- Oppenheimer rates AXP Outperform, a bullish rating, as of Apr 4, 2023.
- When did Oppenheimer last change its view on AXP?
- On Apr 4, 2023, Oppenheimer cuts its price target to $180 from $182, keeps Outperform.
- How does Oppenheimer's AXP target compare with other analysts?
- Across 4 firms with a AXP price target in the last 12 months, the median target is $384.50.
More AXP rating histories
- BMO Capital Markets4
- Piper Sandler4
- DZ Bank4
- Monness, Crespi, Hardt9
- Rothschild & Co Redburn3
- BofA Securities4
- Robert W. Baird4
- J.P. Morgan4
- Citigroup4
- Barclays8
- Morgan Stanley7
- Deutsche Bank4
- Stephens5
- RBC Capital Markets3
All Oppenheimer ratingsAXP news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.